###begin article-title 0
Triose Phosphate Isomerase Deficiency Is Caused by Altered Dimerization-Not Catalytic Inactivity-of the Mutant Enzymes
###end article-title 0
###begin p 1
Conceived and designed the experiments: SK MR. Performed the experiments: MR GH. Wrote the paper: SK MR HL MB
###end p 1
###begin p 2
###xml 714 721 714 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 532 537 <span type="species:ncbi:9606">human</span>
###xml 667 672 <span type="species:ncbi:4932">yeast</span>
###xml 1538 1543 <span type="species:ncbi:4932">yeast</span>
###xml 1813 1818 <span type="species:ncbi:9606">human</span>
Triosephosphate isomerase (TPI) deficiency is an autosomal recessive disorder caused by various mutations in the gene encoding the key glycolytic enzyme TPI. A drastic decrease in TPI activity and an increased level of its substrate, dihydroxyacetone phosphate, have been measured in unpurified cell extracts of affected individuals. These observations allowed concluding that the different mutations in the TPI alleles result in catalytically inactive enzymes. However, despite a high occurrence of TPI null alleles within several human populations, the frequency of this disorder is exceptionally rare. In order to address this apparent discrepancy, we generated a yeast model allowing us to perform comparative in vivo analyses of the enzymatic and functional properties of the different enzyme variants. We discovered that the majority of these variants exhibit no reduced catalytic activity per se. Instead, we observed, the dimerization behavior of TPI is influenced by the particular mutations investigated, and by the use of a potential alternative translation initiation site in the TPI gene. Additionally, we demonstrated that the overexpression of the most frequent TPI variant, Glu104Asp, which displays altered dimerization features, results in diminished endogenous TPI levels in mammalian cells. Thus, our results reveal that enzyme deregulation attributable to aberrant dimerization of TPI, rather than direct catalytic inactivation of the enzyme, underlies the pathogenesis of TPI deficiency. Finally, we discovered that yeast cells expressing a TPI variant exhibiting reduced catalytic activity are more resistant against oxidative stress caused by the thiol-oxidizing reagent diamide. This observed advantage might serve to explain the high allelic frequency of TPI null alleles detected among human populations.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 74 77 74 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider1">[1]</xref>
###xml 331 334 331 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 534 537 534 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 539 542 539 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider3">[3]</xref>
###xml 1004 1007 1004 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 1009 1012 1009 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Olah1">[4]</xref>
###xml 1014 1017 1014 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Watanabe1">[5]</xref>
###xml 1245 1248 1245 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Watanabe1">[5]</xref>
###xml 1249 1252 1249 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Neel1">[9]</xref>
###xml 1476 1479 1476 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Mohrenweiser2">[7]</xref>
###xml 1481 1485 1481 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Mohrenweiser3">[10]</xref>
###xml 1486 1490 1486 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Merkle1">[12]</xref>
###xml 842 850 <span type="species:ncbi:9606">patients</span>
###xml 1089 1094 <span type="species:ncbi:9606">human</span>
###xml 1236 1244 <span type="species:ncbi:9606">patients</span>
###xml 1269 1273 <span type="species:ncbi:10090">mice</span>
###xml 1469 1475 <span type="species:ncbi:9606">humans</span>
Triosephosphate isomerase deficiency has been initially described in 1965 [1]. It is a unique glycolytic enzymopathy with autosomal recessive inheritance that is characterized by chronic haemolytic anaemia, cardiomyopathy, susceptibility to infections, severe neurological dysfunction, and, in most cases, death in early childhood [2]. Thirteen different mutations in the respective gene, which is located at chromosome 12p13 and encodes the ubiquitous housekeeping enzyme triosephosphate isomerase (TPI), have been discovered so far [2], [3]. TPI is a crucial glycolytic enzyme and catalyzes the interconversion of dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate. A marked decrease in TPI activity and an accumulation of DHAP have been detected in erythrocyte extracts of homozygous and compound heterozygous TPI deficiency patients. Remarkably, heterozygous individuals are clinically unaffected, even if their residual TPI activity is reduced to about 50% compared to normal activity [2], [4], [5]. Moreover, the frequency of heterozygous unaffected individuals in all human populations investigated is significantly higher than expected from the rare incidence of homozygous or compound heterozygous TPI deficiency patients [5]-[9]. Interestingly, mice studies demonstrated that mutations resulting in catalytically inactive TPI variants (null alleles) led to early prenatal lethality in the homozygous state, an incidence that might also arise in humans [7], [10]-[12].
###end p 4
###begin p 5
###xml 227 230 227 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Orosz1">[13]</xref>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Daar1">[14]</xref>
###xml 555 559 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Arya1">[15]</xref>
###xml 985 988 985 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 990 994 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Orosz1">[13]</xref>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Arya1">[15]</xref>
###xml 1076 1079 1076 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1578 1582 1578 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Daar1">[14]</xref>
###xml 1584 1588 1584 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Perry1">[16]</xref>
###xml 1789 1792 1789 1792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1798 1801 1798 1801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider3">[3]</xref>
###xml 1803 1807 1803 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Valentin1">[17]</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 302 310 <span type="species:ncbi:9606">patients</span>
###xml 649 657 <span type="species:ncbi:9606">patients</span>
###xml 1481 1488 <span type="species:ncbi:9606">persons</span>
Bioinformatic analyses have predicted that the human pathogenic mutations, which are not restricted to a specific domain or region within the enzyme, could affect the substrate binding site or the dimerization interface of TPI [2], [13]. The most prominent missense mutation detected in TPI deficiency patients occurs at codon 104 in the TPI gene encoding aspartic acid instead of glutamic acid within the enzyme (Glu104Asp variant) and accounts for approximately 80% of mutant alleles within Northern European kindreds with clinical TPI deficiency [14], [15]. Remarkably, this variant is the only one observed to be homozygous among TPI deficiency patients. Other amino acid exchanges in the TPI protein, such as Cys41Tyr and Ile170Val, have been predicted to interfere with both the substrate binding and the dimerization site possibly affecting the catalytic activity plus molecular stability of TPI; both pathogenic TPI variants have been identified in unrelated European kindreds [2], [13], [15]. Furthermore, other missense mutations like a mutation at codon 240 in the TPI gene encoding leucine instead of phenylalanine within the enzyme (Phe240Leu variant) could have an effect on the substrate binding site. Other mutations, for instance, the pathogenic TPI variants Gly122Arg or Val154Met could not be assigned to defined domains. However, Perry and Mohrenweiser showed that the Gly122Arg TPI variant, which was identified as an electromorphic variant by screening 3,400 persons in a Caucasian population, is a thermolabile enzyme possibly indicating improper folding [14], [16]. Furthermore, a start codon mutation has been identified in a French family (Met1_AAG mutation, TPI Paris) as well as a frame shift mutation at codon 28 or mutations within the upstream region of the TPI gene [3], [17].
###end p 5
###begin p 6
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Chang1">[18]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Hollan1">[19]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Chang1">[18]</xref>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Hollan1">[19]</xref>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Hollan2">[20]</xref>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Hollan1">[19]</xref>
###xml 1119 1123 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Hollan3">[21]</xref>
###xml 1125 1129 1125 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Hollan4">[22]</xref>
###xml 1453 1457 1453 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Orosz2">[23]</xref>
To date, the best-studied family affected with TPI deficiency is a Hungarian family in which two germ-line identical compound heterozygote brothers have inherited a missense mutation at codon 240 encoding the Phe240Leu TPI variant and a nonsense mutation at codon 145 (Glu145TER) leading to a truncated TPI protein [18], [19]. Interestingly, these brothers are suffering from an atypical moderate form of TPI deficiency, although both have an extremely reduced activity of TPI with less than 5% of normal enzyme activity and a particularly high level of cellular DHAP. Strikingly, only one of the brothers has developed neurological symptoms indicating that the two mutations alone cannot explain the variance in clinical symptoms [18], [19]. In order to gain insight into the molecular processes causing the different phenotypes of the two brothers, studies have been performed that demonstrate variations in the levels of antioxidants [20], in lymphocyte TPI activity [19], in red blood cell membrane fluidity and enzyme activities and in the molecular composition of phospholipid subclasses between the two brothers [21], [22]. Moreover, it has been discovered that the Phe240Leu TPI variant binds with higher affinity to a yet unidentified component of the red blood cell membrane and to microtubules in comparison to wild-type TPI, leading to the assumption that this process could contribute to the extremely low TPI activity in the disease state [23].
###end p 6
###begin p 7
According to the above-mentioned data, it is quite obvious that further functional analysis of the different TPI variants is mandatory for comprehending the molecular mechanisms underlying pathogenesis in TPI deficiency.
###end p 7
###begin title 8
Methods
###end title 8
###begin title 9
Plasmid construction and mutagenesis
###end title 9
###begin p 10
###xml 929 932 929 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1076 1079 1076 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 1086 1089 1086 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 1179 1183 1179 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Mumberg1">[24]</xref>
###xml 1197 1200 1197 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 1207 1210 1207 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 1286 1290 1286 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Mumberg1">[24]</xref>
###xml 141 146 <span type="species:ncbi:9606">human</span>
We used the cDNA clones pOTB7-MGC14348 (IRALp962K2120 (RZPD); accession number BC007812) and plasmid pACT2-NTint5, which was isolated from a human fetal brain cDNA library (Clontech) for the generation of the different TPI expression plasmids described in this study. Constructs encoding the TPI variants TPI Met1_AAG (TPI Paris) or TPI Phe240Leu, respectively, were produced by PCR using oligonucleotides introducing the respective mutation as indicated in the Supporting Information. To construct expression plasmids encoding the TPI variants Cys41Tyr, Glu104Asp, Gly122Arg and Ile170Val, the diverse mutations were introduced via PCR using the respective oligonucleotide pairs, which overlap in 5' to 3' direction as well as in 3' to 5' direction. Then, the two resultant PCR fragments were utilized as DNA templates for a subsequent PCR applying oligonucleotides designed for the amplification of the full coding sequence of TPI (please refer to the Supporting Information for oligonucleotide sequences). Afterwards, the DNA fragments were purified and subcloned into the BamHI and XhoI sites of the centromeric expression vector p416GPD (GeneBank accession number DQ269148, [24]) or into the BamHI and XhoI sites of the high-copy expression vector p426GPD, respectively (DQ019861, [24]).
###end p 10
###begin p 11
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 228 231 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 17 22 <span type="species:ncbi:4932">yeast</span>
For the directed yeast two-hybrid analysis, we generated the respective bait and prey constructs encoding the various LexA-TPI or AD-TPI fusion proteins by ligating the different DNA fragments amplified by PCR into the SalI and NotI sites of the bait plasmid pBTM117c or the prey plasmid pACT4-1b.
###end p 11
###begin p 12
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 282 290 282 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Met1_AAG</sub>
###xml 383 391 383 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser3_TER</sub>
###xml 543 546 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 552 555 552 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 79 84 <span type="species:ncbi:9606">human</span>
To create the mammalian expression plasmids encoding an N-terminal fragment of human TPI fused to the green fluorescent protein (GFP), the first 200 bp of the TPI coding sequences were amplified via PCR using the oligonucleotide pair TPI-pEGFPN1-s-Sal1 and TPI-pEGFPN1-as-BamH1, TPIMet1_AAG-pEGFPN1-s-Sal1 and TPI-pEGFPN1-as-BamH1 for introducing a mutation at the start codon or TPISer3_TER-pEGFPN1-s-Sal1 and TPI-pEGFPN1-as-BamH1 for introducing an artificial stop codon. Subsequently, the PCR fragments were purified and subcloned into the SalI and BamHI sites of the expression vector pEGFP-N1 (Clontech, U55762).
###end p 12
###begin p 13
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Ralser1">[25]</xref>
The mammalian expression plasmids pTL-Flag-TPI-WT and pTL-Flag-TPI-Glu104Asp were generated by subcloning the corresponding DNA fragments from pACT-TPI-WT or pACT-TPI-Glu104Asp into the XhoI/NotI sites of the vector pTL-FlagC, respectively. PCR was performed under conditions described earlier [25] and all resultant products were verified by sequencing.
###end p 13
###begin title 14
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast strains and cultivation
###end title 14
###begin p 15
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a his3</italic>
###xml 40 46 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1 leu2</italic>
###xml 51 58 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0 met15</italic>
###xml 63 69 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0 ura3</italic>
###xml 74 75 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</italic>
###xml 77 81 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Brachmann1">[26]</xref>
###xml 98 104 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a his3</italic>
###xml 109 147 89 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">200 trp1&#8211;901 leu2&#8211;3,11 gal8 canR cyh2R</italic>
###xml 149 153 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Goehler1">[27]</xref>
###xml 247 251 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tpi1</italic>
###xml 269 275 245 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a his3</italic>
###xml 280 286 252 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1 leu2</italic>
###xml 291 298 259 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0 met15</italic>
###xml 303 309 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0 ura3</italic>
###xml 314 326 274 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0 LEU2::tpi1</italic>
###xml 332 336 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEU2</italic>
###xml 451 455 411 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEU2</italic>
###xml 457 460 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tpi</italic>
###xml 467 471 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEU2</italic>
###xml 473 476 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tpi</italic>
###xml 543 547 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI1</italic>
###xml 626 632 586 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">method</xref>
###xml 632 636 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schiestl1">[28]</xref>
###xml 671 675 631 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-leu</sup>
###xml 911 915 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Compagno1">[29]</xref>
###xml 916 920 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Ciriacy1">[31]</xref>
###xml 960 964 920 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI1</italic>
###xml 1221 1225 1181 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Yamaji1">[32]</xref>
###xml 1372 1376 1332 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Harju1">[33]</xref>
###xml 1378 1382 1338 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Ralser2">[34]</xref>
###xml 1431 1435 1391 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEU2</italic>
###xml 1479 1488 1439 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 1517 1521 1473 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI1</italic>
###xml 1556 1560 1512 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI1</italic>
###xml 1638 1647 1594 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 1800 1809 1752 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 790 795 <span type="species:ncbi:4932">yeast</span>
###xml 982 987 <span type="species:ncbi:4932">yeast</span>
###xml 1247 1252 <span type="species:ncbi:4932">yeast</span>
###xml 1511 1516 <span type="species:ncbi:4932">yeast</span>
###xml 1648 1653 <span type="species:ncbi:4932">yeast</span>
Wild-type strains BY4741 (MATa his3Delta1 leu2Delta0 met15Delta0 ura3Delta0) [26] and L40ccua (MATa his3Delta200 trp1-901 leu2-3,11 gal8 canR cyh2R) [27] were grown in rich medium (YPD) supplemented with 2% glucose. For the generation of the Deltatpi1 strain MR100 (MATa his3Delta1 leu2Delta0 met15Delta0 ura3Delta0 LEU2::tpi1) the LEU2 coding sequence was amplified via PCR using the plasmid pACT2 (Clontech) as DNA template and the oligonucleotides LEU2::tpi-s and LEU2::tpi-as that each encompasses a 35 nucleotide region homologous to the TPI1 coding sequence. After transformation of BY4741 cells via the lithium acetate method[28], transformants were selected on SC-leu medium (synthetic complete medium without leucine) supplemented with 3% (v/v) ethanol/0.1% (v/v) glucose, because yeast cells deficient for the Tpi1 enzyme are unable to grow on medium solely supplemented with glucose as carbon source [29]-[31]. To verify the gene replacement of the TPI1 coding sequence, yeast clones exhibiting no growth on media supplemented with glucose as carbon source have been selected and the correct insertion of the DNA fragment was confirmed by PCR and by western blot analysis using a polyclonal TPI serum (1:4000, [32]). The preparation of yeast genomic DNA, ethanol lysates, SDS-PAGE and immunoblotting were performed using standard protocols as described earlier [33], [34]. To further exclude a second integration of the LEU2 marker gene in the genome of the generated Deltatpi1 strain, the wild-type yeast TPI1 gene was recombined back into the TPI1 locus and transformants were tested for the loss of leucine prototrophy. One Deltatpi1 yeast clone that has been verified by this set of experiments was named MR100 and used for our experimental approaches. If not indicated otherwise, all Deltatpi1 cells were grown in media supplemented with 3% ethanol and 0.1% glucose.
###end p 15
###begin p 16
###xml 53 62 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 262 270 258 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-leu-ura</sup>
###xml 748 752 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Mumberg1">[24]</xref>
###xml 827 830 823 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPD</italic>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 448 453 <span type="species:ncbi:4932">yeast</span>
###xml 684 689 <span type="species:ncbi:4932">yeast</span>
###xml 737 742 <span type="species:ncbi:4932">yeast</span>
###xml 969 974 <span type="species:ncbi:4932">yeast</span>
###xml 1142 1147 <span type="species:ncbi:4932">yeast</span>
For the complementation analyses, we transformed the Deltatpi1 strain MR100 with centromeric plasmids for the expression of the human TPI variants (Met1_AAG, Cys41Tyr, Glu104Asp, Gly122Arg, Ile170Val and Phe240Leu) as indicated and selected single colonies on SC-leu-ura synthetic media supplemented with 3% ethanol/0.1% glucose. Then, the obtained transformants were transferred onto media plates containing glucose as carbon source allowing only yeast cells with functional TPI to grow as well as onto plates containing 3% ethanol/0.1% glucose as control. For this analysis, centromeric plasmids were used for cloning purposes, since these plasmids are known to be highly stable in yeast and are generally present as a single copy per yeast cell [24]. To prevent unwanted regulatory effects in our analyses, the constitutive GPD promoter was chosen for the expression of exogenous TPI. Additionally, to evaluate the biological reliability of our system, we expressed yeast Tpi1 from a centromeric plasmid in the strain MR100 as well. Enzymatic Tpi activity was determined as described below and compared to the enzyme activity of wild-type yeast strain BY4741. No significant differences in Tpi activity were observed in case the Tpi1 enzyme was expressed from the centromeric plasmid or from the genome (data not shown).
###end p 16
###begin p 17
###xml 14 23 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 138 142 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Heeren1">[35]</xref>
###xml 240 243 236 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 824 828 810 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Heeren1">[35]</xref>
###xml 24 29 <span type="species:ncbi:4932">yeast</span>
###xml 168 173 <span type="species:ncbi:4932">yeast</span>
###xml 797 802 <span type="species:ncbi:4932">yeast</span>
Resistance of Deltatpi1 yeast expressing wild-type or the different pathogenic TPI variants to oxidants was analyzed as described earlier [35]. Briefly, the respective yeast cultures were grown to stationary phase and serially diluted to OD600 values of 3.0, 1.0, 0.3 and 0.1. Then, 10 microl aliquots of each culture were spotted onto SC plates containing various concentrations of hydrogen peroxide (1-4 mM; in 0.5 mM steps) tert-butyl hydroperoxide (0.6-2 mM; 0.2 mM steps), cumene hydroperoxide (0.05-0.25 mM; 0.05 mM steps) and diamide (1.2-1.9 mM; 0.1 mM steps). Sensitivity was determined by comparing the growth between the different strains after plates were incubated for 3 days at 28degreesC. Aberrant enrichment of reactive oxygen species was determined by dihydroethidium staining of yeast as described earlier [35].
###end p 17
###begin title 18
###xml 9 14 <span type="species:ncbi:4932">yeast</span>
Directed yeast two-hybrid analysis
###end title 18
###begin p 19
###xml 722 726 716 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 859 863 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Ralser3">[36]</xref>
###xml 1007 1011 998 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Ralser3">[36]</xref>
###xml 100 105 <span type="species:ncbi:4932">yeast</span>
###xml 269 274 <span type="species:ncbi:4932">yeast</span>
###xml 524 529 <span type="species:ncbi:4932">yeast</span>
###xml 626 631 <span type="species:ncbi:4932">yeast</span>
To investigate the dimerization behavior of the different pathogenic TPI variants, we exploited the yeast two-hybrid system. We generated a number of bait and prey plasmids as described above and in the Supporting Information. These plasmids were used to transform the yeast strain L40ccua to express the different bait and prey proteins in various combinations as indicated in the corresponding figures. Transformants were selected on SC media lacking tryptophan and leucine. To analyze the activity of the reporter genes, yeast clones were spotted onto SC medium lacking tryptophan, leucine, histidine and uracil. Growth of yeast on selective media was analyzed after incubation of plates for 48-72 h at 30degreesC. The lacZ reporter gene activity was analyzed using an assay based on o-nitrophenyl-beta-D-galactopyranoside (Applichem) as described earlier [36]. For the detection of the bait and prey proteins in the immunoblot analysis, the Gal4AD antibody (Sigma, 1:5000) or the polyclonal lexA serum ([36], 1:5000) was used.
###end p 19
###begin title 20
TPI activity assay
###end title 20
###begin p 21
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Maitra1">[37]</xref>
###xml 886 889 872 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">340</sub>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 63 68 <span type="species:ncbi:4932">yeast</span>
###xml 192 197 <span type="species:ncbi:4932">yeast</span>
###xml 523 528 <span type="species:ncbi:4932">yeast</span>
To measure the catalytic activity of the human TPI variants in yeast, an enzyme-coupled assay based on a protocol developed by Maitra and Lobo was performed [37]. Briefly, the same numbers of yeast cells from logarithmically grown cultures were collected. Then, the cells were washed and frozen at -80degreesC. After thawing, the cells were resuspended in PBS, pH 7.4 containing a protease inhibitor cocktail ("Complete", Roche) and lysed using glass beads (425-600 microm, Sigma). The total protein concentration for each yeast lysate was determined using a Bradford assay (Biorad). Then, equal protein concentrations were added to PBS buffer containing 1 U glycerol-3-phosphate dehydrogenase and 0.3 mM NADH (Sigma). Subsequently, the enzymatic reaction was started by addition of 10 microl 40 mM glyceraldehyde-3-phosphate (Sigma). The oxidation of NADH was followed measuring the OD340 in 5 s intervals for 3 min using a spectrophotometer (Amersham Ultrospec). Afterwards, the enzymatic activity of TPI under steady-state conditions was calculated as average substrate conversion per minute and the activity of the pathogenic TPI variants was compared to the activity of the wild-type enzyme.
###end p 21
###begin title 22
Mammalian cell culture and transfection
###end title 22
###begin p 23
###xml 194 195 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 435 436 425 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 600 604 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Ralser2">[34]</xref>
###xml 940 944 930 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Yamaji1">[32]</xref>
###xml 99 105 <span type="species:ncbi:9913">bovine</span>
COS1 cells were grown in Dulbecco's modified Eagle medium (DMEM, Gibco) supplemented with 5% fetal bovine serum, 50 U/ml penicillin and 50 microg/ml streptomycin (Biochrom) in a humidified 5% CO2 atmosphere at 37degreesC. Transfection was performed using Polyfect (Qiagen) as recommended by the manufacturer. To prepare cell lysates, the cells were washed in PBS and lysed in a buffer composed of 50 mM Tris-HCl, 100 mM NaCl, 5 mM MgCl2, 0.5% NP40, 1 mM EDTA, pH 8.8, 25 U/ml benzonase (Merck) and 2.5% protease inhibitors ("complete", Roche). SDS-PAGE and immunoblotting were performed as described [34]. GFP fusion proteins were detected using a monoclonal GFP antibody (Roche, 1:2000) and FLAG-tagged fusion proteins were visualized by using a polyclonal antibody directed against the FLAG tag (Sigma, 1:5000). Tubulin was detected using a monoclonal antibody (Sigma, 1:2000) and endogenous TPI was detected by using a polyclonal serum ([32], 1:5000).
###end p 23
###begin title 24
Structural visualization
###end title 24
###begin p 25
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kinoshita1">[38]</xref>
TPI structural coordinates were obtained from Kinoshita et al (MMDB: 32814, [38] ) and visualized using the Cn3D software package (NCBI), version 4.1.
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 67 72 <span type="species:ncbi:4932">yeast</span>
Human wild-type and pathogenic TPI variants complement the loss of yeast Tpi1 in vivo
###end title 27
###begin p 28
###xml 390 393 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Orosz1">[13]</xref>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Daar1">[14]</xref>
###xml 410 416 410 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g001">Fig. 1</xref>
###xml 433 440 <span type="species:ncbi:9606">patient</span>
Structure function relationship investigations have predicted that the mutations identified to be responsible for TPI deficiency may affect the tertiary or quaternary structure of TPI, hence, resulting in a strong reduction in the catalytic activity of the enzyme as determined within affected individuals; however, they are not restricted to a specific domain or region within the enzyme ([2], [13], [14] and Fig. 1). Nevertheless, patient's metabolites do highly depend on the genetic background and environmental factors. Therefore, a model system allowing study of the enzymatic and functional properties of wild-type and pathogenic TPI variants without additional side effects due to differing environment and genetic background is required to gaining insights into the molecular mechanism implicated in TPI deficiency.
###end p 28
###begin p 29
###xml 363 370 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 402 411 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 447 451 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI1</italic>
###xml 1061 1065 1057 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI1</italic>
###xml 1072 1079 1068 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g002">Fig. 2A</xref>
###xml 166 171 <span type="species:ncbi:4932">yeast</span>
###xml 441 446 <span type="species:ncbi:4932">yeast</span>
###xml 572 577 <span type="species:ncbi:9606">human</span>
###xml 647 652 <span type="species:ncbi:4932">yeast</span>
###xml 742 747 <span type="species:ncbi:9606">human</span>
###xml 835 840 <span type="species:ncbi:4932">yeast</span>
###xml 858 863 <span type="species:ncbi:9606">human</span>
###xml 914 919 <span type="species:ncbi:4932">yeast</span>
###xml 1004 1009 <span type="species:ncbi:9606">human</span>
###xml 1055 1060 <span type="species:ncbi:4932">yeast</span>
Since it is not feasible to measure the enzymatic activity of one particular TPI enzyme in mammalian cell lines without further endogenous TPI, we decided to exploit yeast as a model system allowing this, since such an approach will give initial insights into potential variations in the enzymatic functionality of the different TPI variants. As described in the Methods section, we have generated the Deltatpi1 strain MR100 deleted for the yeast TPI1 gene in the haploid BY4741 strain background by a single gene replacement approach. To address the question whether the human wild-type and the pathogenic TPI variants may complement the loss of yeast Tpi1 protein, we transformed this strain with centromeric plasmids for the expression of human wild-type or six representative pathogenic TPI variants as indicated. We observed that yeast cells expressing human wild-type TPI were viable on glucose media, while yeast cells containing the empty vector did not grow on glucose media indicating that the human wild-type enzyme complements the loss of the yeast TPI1 gene (Fig. 2A). Remarkably, with the exception of the Met1_AAG TPI variant, all pathogenic TPI variants were viable on glucose plates demonstrating functional activity of these enzymes.
###end p 29
###begin p 30
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI1</italic>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Shi1">[39]</xref>
###xml 268 277 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 408 415 404 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g002">Fig. 2B</xref>
###xml 38 43 <span type="species:ncbi:4932">yeast</span>
###xml 501 506 <span type="species:ncbi:4932">yeast</span>
Given that a missense mutation in the yeast TPI1 gene, which eliminates the catalytic activity of the Tpi1 protein, leads to the inhibition of the inositol synthesis pathways resulting in sensitivity to the drug lithium [39], we dropped 5-fold serial dilutions of the Deltatpi1 strain MR100 expressing the various TPI variants on glucose media supplemented with different concentrations of lithium chloride (Fig. 2B). As expected, we did not observe significant growth differences between the various yeast strains even at high concentrations of lithium chloride further confirming glycolytic functionality of the pathogenic TPI variants.
###end p 30
###begin p 31
###xml 123 132 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 266 273 262 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 346 352 342 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g003">Fig. 3</xref>
###xml 908 914 904 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 1030 1039 1026 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 1086 1092 1078 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g002">Fig. 2</xref>
###xml 106 111 <span type="species:ncbi:4932">yeast</span>
###xml 364 369 <span type="species:ncbi:4932">yeast</span>
###xml 649 654 <span type="species:ncbi:4932">yeast</span>
###xml 723 728 <span type="species:ncbi:4932">yeast</span>
###xml 1040 1045 <span type="species:ncbi:4932">yeast</span>
Finally, we investigated the catalytic activity of the wild-type and the pathogenic TPI variants in MR100 yeast cells. The Deltatpi1 cells expressing the pathogenic TPI variants Cys41Tyr, Glu104Asp, Gly122Arg or Phe240Leu, respectively, exhibited catalytic activity in vivo that was comparable to the catalytic activity of the wild-type protein (Fig. 3). However, yeast cells expressing the Ile170Val TPI variant showed a strong reduction in catalytic activity compared to the wild-type protein and the other pathogenic TPI variants. To rule out that a low intracellular protein level of the Ile170Val TPI variant causes this diminished activity in yeast, we analyzed the expression levels of the different TPI variants in yeast by immunoblot analyses. No differences were detected demonstrating that the decrease in the enzymatic activity of the Ile170Val TPI variant is based on reduced enzymatic activity per se (data not shown). Nevertheless, this residual activity of about 30% is sufficient to suppress the growth defect of Deltatpi1 yeast cells on glucose medium as presented in Fig. 2.
###end p 31
###begin title 32
Indications for an alternative translation initiation start site in the TPI mRNA
###end title 32
###begin p 33
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Orosz3">[40]</xref>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kochetov1">[41]</xref>
###xml 801 805 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kozak1">[42]</xref>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kochetov2">[43]</xref>
###xml 963 967 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Pedersen1">[44]</xref>
###xml 1137 1144 1137 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g004">Fig. 4A</xref>
###xml 1365 1368 1365 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1555 1561 1555 1561 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 1578 1585 1578 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g004">Fig. 4A</xref>
###xml 1635 1644 1635 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 1690 1694 1686 1690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ura</sup>
###xml 1927 1933 1923 1929 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 1976 1983 1972 1979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g004">Fig. 4B</xref>
###xml 2019 2027 2015 2023 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Met1_AAG</sub>
###xml 2103 2106 2099 2102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 2186 2194 2182 2190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser3_TER</sub>
###xml 2327 2331 2323 2327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Gonzalez1">[45]</xref>
###xml 2383 2386 2379 2382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 2532 2535 2528 2531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 2859 2866 2855 2862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g004">Fig. 4C</xref>
###xml 2893 2901 2889 2897 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Met1_AAG</sub>
###xml 2913 2921 2909 2917 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser3_TER</sub>
###xml 2978 2980 2974 2976 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 3044 3047 3040 3043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 38 45 <span type="species:ncbi:9606">patient</span>
###xml 102 107 <span type="species:ncbi:4932">yeast</span>
###xml 234 242 <span type="species:ncbi:9606">patients</span>
###xml 1310 1315 <span type="species:ncbi:4932">yeast</span>
###xml 1645 1650 <span type="species:ncbi:4932">yeast</span>
###xml 1790 1795 <span type="species:ncbi:4932">yeast</span>
###xml 1958 1963 <span type="species:ncbi:4932">yeast</span>
###xml 2050 2055 <span type="species:ncbi:4932">yeast</span>
###xml 2219 2224 <span type="species:ncbi:4932">yeast</span>
###xml 2321 2326 <span type="species:ncbi:4932">yeast</span>
###xml 2526 2531 <span type="species:ncbi:9606">human</span>
The quite evident discrepancy between patient measurements and in vitro data [40] and our findings in yeast clearly support the assumption that other cellular processes are required to cause the extremely low TPI activity measured in patients. On the one hand, a protein's function and activity depends upon the association with its diverse interaction partners occurring in the different cellular compartments. Furthermore, functional diversity of proteins can also be regulated at the translational level due to alternative translation initiation sites within one mRNA transcript probably resulting in protein variants with novel functional properties [41]. Alternative translational start sites occur at a higher frequency within the first 20 codons compared to the frequency in downstream regions [42], [43]. Interestingly, we have noticed that the NetSTART prediction server (), which is based on an algorithm for the prediction of translational start sites [44], gives an exceptionally high confidence score of 0.700 for the ATG codon encoding MET14 within the TPI protein compared to the value of 0.741 for the first start codon (Fig. 4A). Therefore, we analyzed whether the second ATG codon might function as an alternative translational initiation site within the TPI mRNA. To test this, we generated yeast plasmids in which (i) the first ATG codon of the TPI gene was replaced by an AAG (as observed in the TPI Paris family), (ii) an artificial stop codon was placed at codon position 3, and plasmids encoding the (iii) wild-type TPI or (iv) TPI2ndATG as presented in Fig. 4A. After transformation of these plasmids into the Deltatpi1 yeast strain, transformants were plated on SC-ura medium supplemented with 3% ethanol/0.1% glucose. Afterwards, ethanol lysates of the different yeast cultures were prepared and the expression level of the different TPI proteins was analyzed by immunoblotting. Wild-type TPI and TPI2ndATG are highly expressed in yeast as shown in Fig. 4B. Interestingly, the TPI variant TPIMet1_AAG was also expressed in yeast demonstrating that the second ATG codon in the TPI gene can be used as translational start site. However, no expression of the TPISer3_TER variant was observed in yeast, hence, this observation could be based on the high activity of nonsense-mediated mRNA decay in yeast [45]. To confirm the use of the second ATG codon in the TPI gene as alternative translational start site in mammalian cell lines, we generated fusion proteins comprising the first 200 nucleotides of human TPI gene containing the mutations described above fused to GFP. Afterwards, COS1 cells were transfected with the respective expression plasmids or with the empty plasmid pEGFP-N1 and incubated for two days to allow expression of the recombinant proteins. Cell lysates were prepared and subsequently analyzed by immunoblotting (Fig. 4C). Both fusion proteins TPIMet1_AAG-GFP and TPISer3_TER-GFP were expressed at similar levels compared to the TPIWT-GFP protein demonstrating that the second ATG codon within the TPI gene can also be used as a translational initiation site in mammalian cells.
###end p 33
###begin p 34
###xml 54 60 54 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 173 182 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 223 229 219 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 299 305 295 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 408 415 404 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g004">Fig. 4D</xref>
###xml 145 150 <span type="species:ncbi:4932">yeast</span>
###xml 183 188 <span type="species:ncbi:4932">yeast</span>
###xml 257 262 <span type="species:ncbi:4932">yeast</span>
###xml 273 278 <span type="species:ncbi:4932">yeast</span>
To this end, we addressed the question whether the TPI2ndATG variant shows evidence of glycolytic functionality. Again, we set up to exploit our yeast model and transformed Deltatpi1 yeast cells with the plasmid p416GPD-TPI2ndATG to express this variant in yeast. However, yeast cells expressing TPI2ndATG were unable to grow on glucose medium indicating that this protein variant has no catalytic activity (Fig. 4D).
###end p 34
###begin title 35
Dimerization behavior of TPI is affected by the different mutations
###end title 35
###begin p 36
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 255 258 255 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 511 514 511 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 516 520 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Daar1">[14]</xref>
###xml 525 531 525 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g001">Fig. 1</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Ralser3">[36]</xref>
###xml 833 837 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Estojak1">[46]</xref>
###xml 839 843 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Serebriiskii1">[47]</xref>
###xml 1324 1340 1324 1340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-trp-leu-his-ura</sup>
###xml 1405 1424 1405 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g005">Fig. 5A, left panel</xref>
###xml 1458 1462 1458 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 1824 1830 1821 1827 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 1932 1938 1929 1935 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 2026 2032 2023 2029 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 2186 2192 2180 2186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 2311 2332 2302 2323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g005">Fig. 5A, middle panel</xref>
###xml 2370 2374 2361 2365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 2616 2636 2607 2627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g005">Fig. 5A, right panel</xref>
###xml 637 642 <span type="species:ncbi:4932">yeast</span>
###xml 1022 1027 <span type="species:ncbi:4932">yeast</span>
###xml 1065 1070 <span type="species:ncbi:4932">yeast</span>
###xml 1268 1273 <span type="species:ncbi:4932">yeast</span>
###xml 1611 1616 <span type="species:ncbi:4932">yeast</span>
###xml 1744 1749 <span type="species:ncbi:4932">yeast</span>
###xml 1867 1872 <span type="species:ncbi:4932">Yeast</span>
###xml 2267 2272 <span type="species:ncbi:4932">yeast</span>
Abnormal dimerization behavior of the pathogenic TPI variants has often been discussed as a feature in the pathogenesis of TPI deficiency due to the fact that several mutations within the TPI gene could influence the dimerization properties of the enzyme [2], e.g., bioinformatic predictions based on domain assignments suggested that the most common mutation at position 104 in the TPI gene, which is located in close proximity to the TPI dimerization interface, might affect the dimerization property of TPI ([2], [14] and Fig. 1). However, experimental support for this assumption is lacking. To address this aspect, we exploited the yeast two-hybrid system, since this system allows not only the investigation of the direct interaction between proteins, but also the relative quantification of altered protein interactions [36], [46], [47]. First, we generated constructs encoding the bait fusion protein LexA-TPI or the prey fusion protein AD-TPI to analyze whether dimerization of TPI can be monitored in a directed yeast two-hybrid study and transformed the yeast strain L40ccua with the respective plasmids. Transformants were isolated and the activity of the reporter genes was monitored via growth on SC medium lacking histidine and uracil. We observed that yeast cells co-expressing LexA-TPI and AD-TPI grew on SC-trp-leu-his-ura medium demonstrating activity of the respective reporter genes (Fig. 5A, left panel). In addition, expression of the lacZ reporter gene was indicated by a blue color shift in a membrane-based beta-galactosidase assay. No activation of the reporter genes was observed in yeast cells expressing the fusion protein LexA-TPI and the AD domain alone demonstrating that complex formation of TPI occurs in the yeast two-hybrid system. Moreover, we analyzed whether wild-type TPI and the TPI2ndATG variant do interact in this system. Yeast cells co-expressing the fusion proteins LexA-TPI and AD-TPI2ndATG exhibited activity of all reporter genes demonstrating that the glycolytic inactive TPI2ndATG variant associates with wild-type TPI. However, the observed beta-galactosidase activity resulting from the interaction between wild-type TPI and the TPI2ndATG variant was lower compared to the beta-galactosidase activity measured in yeast co-expressing wild-type TPI proteins (Fig. 5A, middle panel). To confirm that the differences in lacZ reporter gene activity were not due to different expression levels of the various bait or prey proteins, we analyzed the intracellular levels by immunoblotting and observed no significant differences in intracellular protein concentrations (Fig. 5A, right panel).
###end p 36
###begin p 37
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Serebriiskii1">[47]</xref>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 836 856 836 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g005">Fig. 5B, upper panel</xref>
###xml 1236 1240 1233 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 1429 1449 1426 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g005">Fig. 5B, lower panel</xref>
###xml 1520 1523 1517 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 273 278 <span type="species:ncbi:4932">yeast</span>
###xml 559 564 <span type="species:ncbi:4932">yeast</span>
###xml 699 704 <span type="species:ncbi:4932">yeast</span>
###xml 938 943 <span type="species:ncbi:4932">yeast</span>
###xml 1030 1035 <span type="species:ncbi:4932">yeast</span>
###xml 1404 1409 <span type="species:ncbi:4932">yeast</span>
In the next step, we investigated whether the mutations within the TPI gene might affect the dimerization behavior of the protein by measuring the relative activity of the lacZ reporter gene, which indicates the relative strength of a protein-protein interaction [47]. The yeast strain L40ccua was transformed with the bait construct encoding LexA-TPI in combination with prey constructs encoding the TPI variants AD-Cys41Tyr, AD-Glu104Asp, AD-Gly122Arg, AD-Ile170Val or AD-Phe240Leu, respectively. The relative activity of the lacZ reporter gene measured in yeast co-expressing LexA-TPI in combination with AD-Gly122Arg or AD-Phe240Leu, respectively, was not significantly altered in comparison to yeast co-expressing LexA-TPI and AD-TPI suggesting that these mutations were not affecting the dimerization behavior with wild-type TPI (Fig. 5B, upper panel). Interestingly, a slightly enhanced beta-galactosidase activity was observed in yeast co-expressing LexA-TPI and AD-Ile170Val, whereas a strong enhancement was measured in yeast expressing the fusion proteins LexA-TPI and AD-Cys41Tyr. In addition, the interaction between LexA-TPI and AD-Glu104Asp was greatly reduced as monitored by the strong reduction in the activity of the lacZ reporter gene. Again, analysis of the intracellular levels of the bait and prey proteins by immunoblotting demonstrated that all fusion proteins were expressed in yeast at similar levels (Fig. 5B, lower panel). Thus, these results clearly demonstrated that some mutations in the TPI gene do indeed lead to an altered dimerization behavior of the TPI enzyme.
###end p 37
###begin p 38
###xml 197 200 197 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g005">Fig. 5C</xref>
###xml 512 519 512 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g005">Fig. 5B</xref>
###xml 1118 1124 1112 1118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 1167 1174 1161 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g005">Fig. 5D</xref>
###xml 1232 1238 1226 1232 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 1355 1361 1349 1355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 1587 1594 1581 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 580 585 <span type="species:ncbi:4932">yeast</span>
###xml 646 651 <span type="species:ncbi:4932">yeast</span>
###xml 920 925 <span type="species:ncbi:4932">yeast</span>
###xml 1177 1182 <span type="species:ncbi:4932">Yeast</span>
###xml 1311 1316 <span type="species:ncbi:4932">yeast</span>
###xml 1559 1564 <span type="species:ncbi:9606">human</span>
Since the Glu104Asp TPI variant is the most common pathogenic TPI variant accounting for approximately 80% of TPI deficiency cases and is the only variant identified to occur in a homozygous state [2], we further explored the interaction properties between this variant and the other pathogenic TPI proteins. We generated a bait plasmid encoding LexA-Glu104Asp and expressed this fusion protein in combination with the various AD fusion proteins as indicated (Fig. 5C). As expected from the results presented in Fig. 5B, the beta-galactosidase activity measured in the respective yeast clones was considerably lower compared to the corresponding yeast clones expressing wild-type TPI as bait. Furthermore, no significant alterations in the dimerization properties between the fusion protein LexA-Glu104Asp and the AD-TPI variants Cys41Tyr, Glu104Asp, Gly122Arg, or Phe240Leu, respectively, were detected. Interestingly, yeast co-expressing LexA-Glu104Asp and AD-Ile170Val exhibited a significantly higher beta-galactosidase activity. To this end, we also analyzed the dimerization behavior of wild-type TPI and the TPI2ndATG variant carrying the different mutations (Fig. 5D). Yeast co-expressing wild-type TPI and the different TPI2ndATG variants all displayed a reduced dimerization behavior in comparison to yeast cells expressing wild-type TPI and TPI2ndATG proteins. Even here, dimerization was most affected by the Glu104Asp TPI variant. In sum, our results indicate that the different pathogenic mutations highly influence the dimerization behavior of human TPI under recombinant in vivo conditions.
###end p 38
###begin title 39
Overexpression of the Glu104Asp TPI variant results in reduced expression levels of endogenous TPI
###end title 39
###begin p 40
###xml 588 594 588 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g006">Fig. 6</xref>
###xml 1122 1130 <span type="species:ncbi:9606">patients</span>
The most frequent TPI variant, Glu104Asp, displays strong defects in the dimerization properties compared to wild-type TPI. This suggests that regulatory processes due to aberrant protein dimerization could contribute to the pathogenesis of TPI deficiency, and therefore we directly investigated whether overexpression of this variant would have an impact on the regulation of endogenous TPI. Therefore, we transfected COS1 cells with plasmids designed for the expression of FLAG-tagged wild-type or pathogenic TPI enzyme. Then, cell lysates were prepared and analyzed by immunoblotting (Fig. 6). Strikingly, in comparison to overexpressed wild-type TPI, a strong reduction in the endogenous TPI level was detected in case the Glu104Asp variant was overexpressed (upper panel). Thus, this result clearly demonstrates that endogenous wild-type TPI is deregulated in the presence of a pathogenic TPI variant exhibiting altered dimerization properties, and hence, one could conclude that this apparent feedback mechanism is potentially accountable for the reduced TPI activity measured in the cell extracts of TPI deficiency patients.
###end p 40
###begin title 41
Reduced TPI activity results in increased cellular resistance against the thiol-oxidizing drug diamide
###end title 41
###begin p 42
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Laun1">[48]</xref>
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Floyd1">[50]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Hollan2">[20]</xref>
###xml 423 426 423 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 503 512 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 1370 1376 1366 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g003">Fig. 3</xref>
###xml 1498 1504 1494 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g007">Fig. 7</xref>
###xml 96 101 <span type="species:ncbi:4932">yeast</span>
###xml 178 184 <span type="species:ncbi:9606">humans</span>
###xml 302 309 <span type="species:ncbi:9606">patient</span>
###xml 513 518 <span type="species:ncbi:4932">yeast</span>
###xml 636 641 <span type="species:ncbi:4932">yeast</span>
###xml 787 792 <span type="species:ncbi:4932">yeast</span>
###xml 957 962 <span type="species:ncbi:4932">yeast</span>
###xml 1189 1194 <span type="species:ncbi:4932">yeast</span>
###xml 1268 1273 <span type="species:ncbi:4932">yeast</span>
###xml 1512 1517 <span type="species:ncbi:4932">yeast</span>
Accumulation of reactive oxygen species (ROS) influences chronological and replicative aging in yeast and plays an important role in the pathogenesis of age related disorders in humans [48]-[50]. Interestingly, increased chronic oxidative stress has been detected in a severely affected TPI deficiency patient as well [20]. In the light of this observation we investigated whether the different pathogenic mutations in the TPI gene might cause intracellular accumulation of ROS in exponentially growing Deltatpi1 yeast cultures monitored by dihydroethidium staining. However, no significant differences in red flurorescence between the yeast strains expressing wild-type or the pathogenic TPI variants were observed (data not shown). Finally, we analyzed the resistance of the different yeast strains to oxidants such as hydrogen peroxide, tert-butyl hydroperoxide, cumene hydroperoxide and diamide. No differences in the growth rates between the different yeast strains was monitored on medium containing different concentrations of hydrogen peroxide, tert-butyl hydroperoxide or cumene hydroperoxide, respectively (data not shown). However, we discovered that treatment of the different yeast strains with the thiol-oxidizing drug diamide had an effect. Strikingly, yeast cells expressing Ile170Val TPI, the variant exhibiting a reduced catalytic activity as shown in Fig. 3, were resistant to diamide treatment in comparison to strains expressing wild-type or the other pathogenic TPI variants (Fig. 7). Only yeast cells expressing this TPI variant were able to grow on medium containing 1.7 mM diamide. Thus, this result indicates that a decrease in the catalytic activity of the TPI enzyme mediate cellular resistance against oxidative stress caused by diamide treatment.
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 194 197 194 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Orosz1">[13]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Eber3">[51]</xref>
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 533 536 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Watanabe1">[5]</xref>
###xml 537 540 537 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Neel1">[9]</xref>
###xml 546 554 546 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 606 613 606 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Orosz3">[40]</xref>
###xml 990 994 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Orosz1">[13]</xref>
###xml 1112 1119 1112 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1328 1332 1328 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI1</italic>
###xml 1439 1446 1439 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1623 1632 1623 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 1677 1684 1673 1680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1984 1988 1980 1984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Shi1">[39]</xref>
###xml 2048 2054 2044 2050 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 2157 2160 2153 2156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 2349 2358 2345 2350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 275 283 <span type="species:ncbi:9606">patients</span>
###xml 606 613 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 779 786 <span type="species:ncbi:9606">patient</span>
###xml 908 916 <span type="species:ncbi:9606">patients</span>
###xml 1002 1010 <span type="species:ncbi:9606">patients</span>
###xml 1268 1273 <span type="species:ncbi:4932">yeast</span>
###xml 1299 1304 <span type="species:ncbi:4932">yeast</span>
###xml 1420 1425 <span type="species:ncbi:9606">human</span>
###xml 1463 1468 <span type="species:ncbi:9606">human</span>
###xml 1633 1638 <span type="species:ncbi:4932">yeast</span>
###xml 1818 1823 <span type="species:ncbi:4932">yeast</span>
###xml 2359 2364 <span type="species:ncbi:4932">yeast</span>
Metabolic studies demonstrated that the activity of the TPI enzyme is reduced to 3-20% of the wild-type value as measured in unpurified erythrocyte or muscle extracts of TPI deficiency patients [2], [13], [51]. However, some discrepancies between measurements performed with patients' erythrocytes and a number of observations made in experimental systems and theoretical analyses have been reported over the last few years. As aforementioned, the frequency of TPI null alleles is much higher as the rare incidence of TPI deficiency [5]-[9], and in vitro measurements of a mutant TPI variant purified from E. coli demonstrated that the purified TPI protein carrying the Phe240Leu mutation exhibited a 6-fold higher activity than expected from the measurements performed with the patient erythrocyte extract [40]. Moreover, theoretical calculations demonstrated that the extremely high DHAP level observed in patients' erythrocytes does not correlate with the measured residual TPI activity [13]. Since patients' metabolites highly depend on the genetic background and environmental factors, we have generated an in vivo system allowing analysis of the enzymatic activity of wild-type or pathogenic TPI variants inside a cell without additional side effects. Utilizing yeast genetics, we generated a yeast strain deleted for the TPI1 gene enabling us to investigate the enzymatic and functional properties of a number of human TPI variants in vivo. We showed that human wild-type as well as the pathogenic TPI variants Cys41Tyr, Glu104Asp, Gly122Arg, Ile170Val and Phe240Leu, respectively, all suppress the growth defect of Deltatpi1 yeast on glucose medium providing the first in vivo evidence that these pathogenic variants exhibit catalytic activity. We corroborated this result by demonstrating that the respective yeast clones are not hypersensitive to lithium chloride, a phenotype caused by inactivation of the Tpi1 enzyme due to inhibition of the inositol biosynthesis pathway [39]. Finally, we provided evidence that the catalytic activity per se of all but one pathogenic TPI variant investigated is not affected as a result of the mutation in the TPI gene. Interestingly, the pathogenic TPI variant Ile170Val displayed only about 30% of the wild-type catalytic activity; hence, this activity is sufficient to suppress the growth defect of Deltatpi1 yeast on glucose medium.
###end p 44
###begin p 45
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Orosz2">[23]</xref>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Jung1">[52]</xref>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
Since our results seem to be in sharp contrast to the measured TPI activity in unpurified erythrocyte extracts of TPI deficiency patients at disease stage, they clearly make obvious that regulatory events rather than enzyme inactivity are the basis for this enormous reduction in TPI activity. Indeed it has been reported that binding of TPI to an yet unidentified component of red cell membranes can lessen the activity of TPI [23]. Along this line, Jung and co-workers identified human cofilin as interaction partner of TPI and demonstrated that the Rho activator lysophosphatidic acid leads to translocation of cofilin along with TPI to the plasma membrane. This cofilin-TPI complex then interacts with Na/K-ATPase [52]. Consequently, to elucidate the pathogenesis of TPI deficiency, it is of enormous importance to identify cellular factors that interact with TPI, to investigate whether their association has an effect on the catalytic activity of TPI, and obviously whether the binding is affected by the various mutations.
###end p 45
###begin p 46
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Sawyer1">[53]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Snapka1">[54]</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Yamaji1">[32]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Stamm1">[55]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kochetov1">[41]</xref>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kochetov2">[43]</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kochetov1">[41]</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kozak1">[42]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Henn1">[56]</xref>
###xml 707 711 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Concepcion1">[57]</xref>
###xml 748 752 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Liu1">[58]</xref>
###xml 823 826 823 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1014 1023 1014 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 1440 1444 1436 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Valentin1">[17]</xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 908 913 <span type="species:ncbi:4932">yeast</span>
###xml 1024 1029 <span type="species:ncbi:4932">yeast</span>
###xml 1275 1282 <span type="species:ncbi:9606">patient</span>
At least three different isoelectric TPI variants encoded by the single TPI gene have been observed in human red blood cells [53], [54] or mouse-brain capillary endothelial cells [32]. Furthermore, the Alternative Splicing Database (ASD, [55]) predicts three alternative splice variants for human TPI, but none of them has been identified experimentally to date. Along these lines, protein diversity is often generated by utilizing alternative translation initiation sites [41], [43], mainly if a second start site is located within the first 20 codons [41], [42]. The usage of alternative translation initiation sites have been discussed for disease-causing proteins such as parkin [56], the prion protein [57] and the breast cancer antigen BRCA1 [58]. Here, we provided evidence that the second in-frame ATG codon in the TPI gene encoding MET14 can be used as an alternative translation initiation site in yeast as well as in mammalian cells. However, the resulting protein did not suppress the growth defect of Deltatpi1 yeast on glucose medium indicating that this variant lacks catalytic activity. This result is not unexpected, since this TPI variant lacks the catalytic lysine and at least three residues of the intersubunit interface. Interestingly, a TPI deficiency patient which has inherited a start codon mutation in combination with the mutation at position 104, has a stronger pathology in comparison to Glu104Asp homozygotes [17].
###end p 46
###begin p 47
###xml 245 248 245 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Orosz1">[13]</xref>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Snapka1">[54]</xref>
###xml 425 429 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 624 625 624 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 641 649 641 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Estojak1">[46]</xref>
###xml 669 673 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Serebriiskii1">[47]</xref>
###xml 939 945 939 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 1232 1236 1232 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 1678 1681 1678 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1695 1698 1695 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Schneider2">[2]</xref>
###xml 1703 1709 1703 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g001">Fig. 1</xref>
###xml 1857 1861 1857 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Valentin1">[17]</xref>
###xml 1967 1971 1967 1971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Chang1">[18]</xref>
###xml 2095 2099 2095 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Marianayagam1">[59]</xref>
###xml 2436 2440 2436 2440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Olah2">[60]</xref>
###xml 534 539 <span type="species:ncbi:4932">yeast</span>
Structural alterations of the pathogenic TPI variants have often been speculated to contribute to TPI deficiency as a number of mutations seem to affect the dimerization interface of TPI which forms a stable dimer in most investigated organisms [2], [13], [54]. To address this issue, we have analyzed the dimerization properties between wild-type and the pathogenic TPI variants by a quantitative assay that is based on the lacZ gene as reporter. This allows determination of the relative strength of protein-protein interactions in yeast, however, these values can not be directly correlated with binding constants (e.g. KD) determined by in vitro measurements [46], [47]. We discovered that the dimerization behavior between wild-type TPI and the two pathogenic variants Cys41Tyr and Glu104Asp is strongly altered compared to the dimerization behavior between wild-type proteins. We further observed that the glycolytically inactive TPI2ndATG variant dimerizes with wild-type TPI, although at reduced levels in comparison to the dimerization of wild-type TPI proteins. Finally, we demonstrated that the dimerization between the pathogenic variants also occurred with lower stringency as indicated by the relative activity of the lacZ reporter gene. In the light of these results, it is quite remarkable that the Glu104Asp TPI variant, which displayed the most modified dimerization behavior, is the most common variant observed amongst the affected individuals. Moreover, this variant is the only TPI variant found homozygous among affected individuals; all other mutations occur only in the compound heterozygous state together with the Glu104Asp variant or with an obvious TPI null allele ([2] and Fig. 1). For example, in the TPI Paris family, the start codon mutant (ATG to AAG) has been detected in the heterozygous state with the Glu104Asp variant [17], the Phe240Leu variant observed in the Hungarian family is found together with the Glu145TER null allele [18]. Generally, dimerization between proteins is a substantial process to generate and regulate cellular functions of proteins [59]. Remarkably, we discovered that overexpression of the Glu104Asp variant results in reduced levels of endogenous TPI in mammalian cells. This finding is exciting since recent studies demonstrated that both compound heterozygous brothers of the Hungarian family have reduced TPI mRNA levels compared to their parents and healthy controls [60] suggesting that altered dimer formation resulting in a modified feedback regulation of the TPI enzyme could underlie the pathogenesis of TPI deficiency.
###end p 47
###begin p 48
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Yamaji1">[32]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kosower1">[61]</xref>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kosower2">[62]</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Thorpe1">[63]</xref>
###xml 1247 1251 1247 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Shenton1">[64]</xref>
###xml 1252 1256 1252 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Grant1">[67]</xref>
###xml 1360 1364 1360 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TDH3</italic>
###xml 1418 1419 1418 1419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1420 1421 1420 1421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1421 1425 1421 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Grant1">[67]</xref>
###xml 1806 1810 1806 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-SchuppeKoistinen1">[68]</xref>
###xml 1812 1816 1812 1816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Ravichandran1">[69]</xref>
###xml 1950 1954 1950 1954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Krems1">[70]</xref>
###xml 2160 2164 2160 2164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Buchanan1">[71]</xref>
###xml 2166 2170 2166 2170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Holmgren1">[72]</xref>
###xml 2316 2320 2316 2320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Shenton1">[64]</xref>
###xml 2322 2326 2322 2326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Costa1">[66]</xref>
###xml 2400 2404 2400 2404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Colussi1">[65]</xref>
###xml 2406 2410 2406 2410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-SchuppeKoistinen1">[68]</xref>
###xml 274 279 <span type="species:ncbi:4932">yeast</span>
###xml 790 795 <span type="species:ncbi:4932">yeast</span>
###xml 1189 1194 <span type="species:ncbi:4932">yeast</span>
###xml 1495 1500 <span type="species:ncbi:4932">yeast</span>
###xml 2304 2309 <span type="species:ncbi:4932">yeast</span>
Remarkably, TPI is highly up-regulated under stress conditions in mammalian cells ([32] and Ralser, unpublished observations). Regarding this issue, it is important that expression of the Ile170Val TPI variant with reduced catalytic activity results in higher resistance of yeast to diamide. Diamide is an oxidant which is known to stoichiometrically oxidize small molecules including glutathione (GSH) within red blood cells, but is less effective in oxidizing protein-integrated cysteines [61]. Therefore, diamide treatment results in a rapid decrease in intracellular GSH, thus, leading to oxidative stress [62]. Interestingly, the response mechanisms of eukaryotic cells to oxidative stress are strictly dependent on the compound and its downstream effects [63]. This might explain why yeast cells expressing the TPI variant with reduced catalytic activity were not resistant to all oxidants examined. It is noteworthy to mention that in contrast to diamide, all other oxidants used in this study are hydroperoxides. Treatment with hydroperoxides leads to the inactivation of the Tdh3 protein, the most abundant of the three glyceraldehyde-3-phosphate dehydrogenase (GAPDH) enzymes in yeast, by S-thiolation, carbonlyation or ADP-ribosylation [64]-[67]. GAPDH catalyzes the first downstream reaction after TPI in glycolysis and remarkably, mutants lacking TDH3 were sensitive to a challenge with a lethal dose of H2O2[67]. It is likely that inactivation of GAPDH after peroxide treatment of yeast cells is forestalling the protective effect of TPI variants exhibiting reduced catalytic activity. In this context it is noteworthy to mention that blockage of glycolysis can force an increased influx of metabolites into the pentose phosphate pathway resulting in an elevated cellular NADPH concentration [68], [69] and vice-versa that different mutations introduced in enzymes implicated in this pathway are leading to oxidant-hypersensitive cells [70]. High intracellular NADPH levels are beneficial during conditions of oxidative stress, because NADPH provides the base for several antioxidant enzymes including the thioredoxins or the glutaredoxin system [71], [72]. As aforementioned, the first downstream enzyme of TPI in glycolysis, GAPDH, is specifically inactivated after peroxide treatment of yeast cells [64], [66] and this subject is, interestingly, reflected in mammalian cells as well [65], [68].
###end p 48
###begin p 49
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 306 309 306 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Watanabe1">[5]</xref>
###xml 310 313 310 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Neel1">[9]</xref>
###xml 532 535 532 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Mohrenweiser1">[6]</xref>
###xml 692 696 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Merkle1">[12]</xref>
###xml 893 897 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Merkle1">[12]</xref>
###xml 948 951 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1153 1156 1153 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Watanabe1">[5]</xref>
###xml 1158 1161 1158 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Mohrenweiser1">[6]</xref>
###xml 1204 1207 1204 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1328 1334 1328 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000030-g008">Fig. 8</xref>
###xml 1347 1350 1347 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1406 1409 1406 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1459 1462 1459 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Watanabe1">[5]</xref>
###xml 1464 1468 1464 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Merkle1">[12]</xref>
###xml 1668 1672 1668 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Daar1">[14]</xref>
###xml 1696 1699 1696 1699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 1855 1859 1855 1859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Valentin1">[17]</xref>
###xml 2428 2431 2428 2431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Mohrenweiser1">[6]</xref>
###xml 2433 2437 2433 2437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Hammond1">[73]</xref>
###xml 2619 2622 2619 2622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 1042 1046 <span type="species:ncbi:10090">mice</span>
###xml 1052 1057 <span type="species:ncbi:9606">human</span>
###xml 1138 1144 <span type="species:ncbi:9606">humans</span>
###xml 1234 1242 <span type="species:ncbi:9606">patients</span>
###xml 1442 1447 <span type="species:ncbi:10090">mouse</span>
###xml 1452 1458 <span type="species:ncbi:9606">humans</span>
###xml 2457 2462 <span type="species:ncbi:4932">yeast</span>
In the light of the above-mentioned findings it is quite intriguing that the frequency of heterozygous individuals carrying one inactive TPI allele is quite high. Several studies demonstrated an allelic frequency from roughly 0.002 (Caucasian and Japanese population) to 0.02 (African American population) [5]-[9]. Indeed this number implies that 1 out of 2000 newborn individuals from the latter population would suffer from this tremendous disorder, but less than 100 individuals have been diagnosed with TPI deficiency worldwide [6]. A mutagenesis screen in mice identified four heterozygous TPI mutations that lead to a 50% reduction in catalytic TPI activity in several tissues examined [12]. However, each homozygous or compound heterozygous offspring of these mice, which lacked any detectable phenotypical abnormalities in the heterozygote state, resulted in early embryonic lethality [12]. These results demonstrated that mutations in the TPI gene resulting in a catalytic inactive TPI enzyme cause homozygote embryonic lethality in mice. The human population studies performed are indicating that this situation is reflected in humans as well [5], [6]. Consequently, the occurring mutations in TPI alleles of TPI deficiency patients cannot encode catalytically inactive TPI enzymes. As illustrated and demonstrated in Fig. 8, homozygote TPI null alleles are lethal, since no homozygotes carrying TPI null alleles can be detected in mouse and humans [5], [12]. Furthermore, TPI variants with altered dimerization properties and exhibiting almost normal specific catalytic activity like the Glu104Asp variant, occur in homozygous states causing TPI deficiency [14] or in combination with TPI null alleles, for instance, the TPI Paris (Met1_AAG; heterozygous with Glu104Asp) or TPI Alfortwille (frameshift at codon 29; heterozygous with Glu104Asp) [17] representing the compound heterozygote state, whereas heterozygote individuals having inherited a heterozygote null allele in combination with the wild-type allele are healthy and might have a heterozygous advantage. Regarding this issue, one should keep in mind that advantage of heterozygous state has been demonstrated for sickle cell anemia and cystic fibrosis, two other genetic disorders. Strikingly, the allelic frequency of mutations causing cystic fibrosis is comparable to the frequency of heterozygous TPI mutations in the examined Afro-American population [6], [73]. The fact that the yeast strain harboring the TPI variant with reduced catalytic activity is more resistant to specific oxidative stress is a first indication that mutations within TPI alleles resulting in catalytically impaired enzymes could confer an advantage to certain stress stimuli or other environmental conditions.
###end p 49
###begin title 50
Supporting Information
###end title 50
###begin p 51
(0.06 MB DOC)
###end p 51
###begin p 52
Click here for additional data file.
###end p 52
###begin p 53
The authors would like to thank Ryoichi Yamaji (Osaka Prefecture University, Japan) for providing the TPI antiserum and Daniel Shenton and Chris Grant (University of Manchester, United Kingdom) for help with the TPI activity assays. We are also grateful to Miriam Greenberg (Wayne State University, Detroit, USA), Mario Albrecht (Max Planck Institute for Informatics, Saarbruecken, Germany), Ian Dawes (University of New South Wales, Sydney, Australia), Michel Cohen-Solal (Academie des Sciences, Paris, France), and our lab members Josmar Langner and Ute Nonhoff for their help, support and critical discussions.
###end p 53
###begin title 54
References
###end title 54
###begin article-title 55
Hereditary Hemolytic Anemia with Triosephosphate Isomerase Deficiency.
###end article-title 55
###begin article-title 56
Triosephosphate isomerase deficiency: historical perspectives and molecular aspects.
###end article-title 56
###begin article-title 57
Hematologically important mutations: triosephosphate isomerase.
###end article-title 57
###begin article-title 58
Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease.
###end article-title 58
###begin article-title 59
###xml 45 51 <span type="species:ncbi:9606">humans</span>
Molecular analysis of a series of alleles in humans with reduced activity at the triosephosphate isomerase locus.
###end article-title 59
###begin article-title 60
###xml 88 93 <span type="species:ncbi:9606">human</span>
Frequency and distribution of rare electrophoretic mobility variants in a population of human newborns in Ann Arbor, Michigan.
###end article-title 60
###begin article-title 61
###xml 83 90 <span type="species:ncbi:9606">infants</span>
Elevated frequency of carriers for triosephosphate isomerase deficiency in newborn infants.
###end article-title 61
###begin article-title 62
###xml 98 104 <span type="species:ncbi:9606">people</span>
Prevalence of partial deficiency of red cell triosephosphate isomerase in Germany-a study of 3000 people.
###end article-title 62
###begin article-title 63
###xml 64 72 <span type="species:ncbi:9606">children</span>
Search for mutations altering protein charge and/or function in children of atomic bomb survivors: final report.
###end article-title 63
###begin article-title 64
###xml 67 74 <span type="species:ncbi:9606">infants</span>
Frequency of enzyme deficiency variants in erythrocytes of newborn infants.
###end article-title 64
###begin article-title 65
Hereditary deficiency of triosephosphate isomerase in four unrelated families.
###end article-title 65
###begin article-title 66
###xml 86 98 <span type="species:ncbi:10090">Mus musculus</span>
Characterization of triosephosphate isomerase mutants with reduced enzyme activity in Mus musculus.
###end article-title 66
###begin article-title 67
Triosephosphate isomerase deficiency: predictions and facts.
###end article-title 67
###begin article-title 68
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human triose-phosphate isomerase deficiency: a single amino acid substitution results in a thermolabile enzyme.
###end article-title 68
###begin article-title 69
Evidence for founder effect of the Glu104Asp substitution and identification of new mutations in triosephosphate isomerase deficiency.
###end article-title 69
###begin article-title 70
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human triosephosphate isomerase: substitution of Arg for Gly at position 122 in a thermolabile electromorph variant, TPI-Manchester.
###end article-title 70
###begin article-title 71
Triose phosphate isomerase deficiency in 3 French families: two novel null alleles, a frameshift mutation (TPI Alfortville) and an alteration in the initiation codon (TPI Paris).
###end article-title 71
###begin article-title 72
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human triosephosphate isomerase deficiency resulting from mutation of Phe-240.
###end article-title 72
###begin article-title 73
Hereditary triosephosphate isomerase (TPI) deficiency: two severely affected brothers one with and one without neurological symptoms.
###end article-title 73
###begin article-title 74
[Glycolytic enzyme defects and neurodegeneration].
###end article-title 74
###begin article-title 75
Search for the pathogenesis of the differing phenotype in two compound heterozygote Hungarian brothers with the same genotypic triosephosphate isomerase deficiency.
###end article-title 75
###begin article-title 76
Erythrocyte lipids in triose-phosphate isomerase deficiency.
###end article-title 76
###begin article-title 77
Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules.
###end article-title 77
###begin article-title 78
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds.
###end article-title 78
###begin article-title 79
An efficient and economic enhancer mix for PCR.
###end article-title 79
###begin article-title 80
###xml 39 63 39 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 39 63 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications.
###end article-title 80
###begin article-title 81
A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease.
###end article-title 81
###begin article-title 82
###xml 41 46 <span type="species:ncbi:4932">yeast</span>
High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier.
###end article-title 82
###begin article-title 83
###xml 72 96 72 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 72 96 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Glycerol production in a triose phosphate isomerase deficient mutant of Saccharomyces cerevisiae.
###end article-title 83
###begin article-title 84
###xml 48 72 48 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 48 72 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Metabolic engineering of glycerol production in Saccharomyces cerevisiae.
###end article-title 84
###begin article-title 85
###xml 65 89 65 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 65 89 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Physiological effects of seven different blocks in glycolysis in Saccharomyces cerevisiae.
###end article-title 85
###begin article-title 86
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Hypoxic up-regulation of triosephosphate isomerase expression in mouse brain capillary endothelial cells.
###end article-title 86
###begin article-title 87
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
Rapid isolation of yeast genomic DNA: Bust n' Grab.
###end article-title 87
###begin article-title 88
Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways.
###end article-title 88
###begin article-title 89
###xml 104 109 <span type="species:ncbi:4932">yeast</span>
The role of respiration, reactive oxygen species and oxidative stress in mother cell-specific ageing of yeast strains defective in the RAS signalling pathway.
###end article-title 89
###begin article-title 90
###xml 16 21 <span type="species:ncbi:4932">yeast</span>
Generation of a yeast two-hybrid strain suitable for competitive protein binding analysis.
###end article-title 90
###begin article-title 91
###xml 50 55 <span type="species:ncbi:4932">yeast</span>
A kinetic study of glycolytic enzyme synthesis in yeast.
###end article-title 91
###begin article-title 92
###xml 47 52 <span type="species:ncbi:9606">human</span>
Structure of a high-resolution crystal form of human triosephosphate isomerase: improvement of crystals using the gel-tube method.
###end article-title 92
###begin article-title 93
Genetic perturbation of glycolysis results in inhibition of de novo inositol biosynthesis.
###end article-title 93
###begin article-title 94
Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency.
###end article-title 94
###begin article-title 95
###xml 96 101 <span type="species:ncbi:4932">yeast</span>
Interrelations between the efficiency of translation start sites and other sequence features of yeast mRNAs.
###end article-title 95
###begin article-title 96
Adherence to the first-AUG rule when a second AUG codon follows closely upon the first.
###end article-title 96
###begin article-title 97
###xml 69 74 <span type="species:ncbi:9606">human</span>
The role of alternative translation start sites in the generation of human protein diversity.
###end article-title 97
###begin article-title 98
Neural network prediction of translation initiation sites in eukaryotes: perspectives for EST and genome analysis.
###end article-title 98
###begin article-title 99
###xml 32 56 32 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 32 56 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Nonsense-mediated mRNA decay in Saccharomyces cerevisiae.
###end article-title 99
###begin article-title 100
Correlation of two-hybrid affinity data with in vitro measurements.
###end article-title 100
###begin article-title 101
###xml 93 98 <span type="species:ncbi:4932">yeast</span>
Uses of lacZ to study gene function: evaluation of beta-galactosidase assays employed in the yeast two-hybrid system.
###end article-title 101
###begin article-title 102
###xml 21 45 21 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 21 45 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Aged mother cells of Saccharomyces cerevisiae show markers of oxidative stress and apoptosis.
###end article-title 102
###begin article-title 103
###xml 43 48 <span type="species:ncbi:4932">yeast</span>
Oxygen stress: a regulator of apoptosis in yeast.
###end article-title 103
###begin article-title 104
Antioxidants, oxidative stress, and degenerative neurological disorders.
###end article-title 104
###begin article-title 105
Triosephosphate isomerase deficiency: haemolytic anaemia, myopathy with altered mitochondria and mental retardation due to a new variant with accelerated enzyme catabolism and diminished specific activity.
###end article-title 105
###begin article-title 106
Interaction of cofilin with triose-phosphate isomerase contributes glycolytic fuel for Na,K-ATPase via Rho-mediated signaling pathway.
###end article-title 106
###begin article-title 107
###xml 11 16 <span type="species:ncbi:9606">human</span>
Studies on human triosephosphate isomerase. II. Nature of the electrophoretic multiplicity in erythrocytes.
###end article-title 107
###begin article-title 108
Comparison of the electrophoretic properties of triosephosphate isomerases of various tissues and species.
###end article-title 108
###begin article-title 109
ASD: a bioinformatics resource on alternative splicing.
###end article-title 109
###begin article-title 110
Pathogenic mutations inactivate parkin by distinct mechanisms.
###end article-title 110
###begin article-title 111
###xml 59 64 <span type="species:ncbi:9606">human</span>
The codon for the methionine at position 129 (M129) in the human prion protein provides an alternative initiation site for translation and renders individuals homozygous for M129 more susceptible to prion disease.
###end article-title 111
###begin article-title 112
Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DeltaBRCA1(17aa).
###end article-title 112
###begin article-title 113
The power of two: protein dimerization in biology.
###end article-title 113
###begin article-title 114
Triosephosphate isomerase deficiency: consequences of an inherited mutation at mRNA, protein and metabolic levels.
###end article-title 114
###begin article-title 115
Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfide.
###end article-title 115
###begin article-title 116
Diamide: an oxidant probe for thiols.
###end article-title 116
###begin article-title 117
Cells have distinct mechanisms to maintain protection against different reactive oxygen species: oxidative-stress-response genes.
###end article-title 117
###begin article-title 118
###xml 107 131 107 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 101 106 <span type="species:ncbi:4932">yeast</span>
###xml 107 131 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Protein S-thiolation targets glycolysis and protein synthesis in response to oxidative stress in the yeast Saccharomyces cerevisiae.
###end article-title 118
###begin article-title 119
H2O2-induced block of glycolysis as an active ADP-ribosylation reaction protecting cells from apoptosis.
###end article-title 119
###begin article-title 120
###xml 68 92 68 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 68 92 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Hydrogen peroxide-induced carbonylation of key metabolic enzymes in Saccharomyces cerevisiae: the involvement of the oxidative stress response regulators Yap1 and Skn7.
###end article-title 120
###begin article-title 121
Differential protein S-thiolation of glyceraldehyde-3-phosphate dehydrogenase isoenzymes influences sensitivity to oxidative stress.
###end article-title 121
###begin article-title 122
###xml 16 21 <span type="species:ncbi:9606">human</span>
S-thiolation of human endothelial cell glyceraldehyde-3-phosphate dehydrogenase after hydrogen peroxide treatment.
###end article-title 122
###begin article-title 123
S-thiolation of glyceraldehyde-3-phosphate dehydrogenase induced by the phagocytosis-associated respiratory burst in blood monocytes.
###end article-title 123
###begin article-title 124
###xml 11 35 11 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 11 35 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Mutants of Saccharomyces cerevisiae sensitive to oxidative and osmotic stress.
###end article-title 124
###begin article-title 125
Redox regulation: a broadening horizon.
###end article-title 125
###begin article-title 126
Antioxidant function of thioredoxin and glutaredoxin systems.
###end article-title 126
###begin article-title 127
Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
###end article-title 127
###begin title 128
Figures and Tables
###end title 128
###begin title 129
###xml 20 25 <span type="species:ncbi:9606">human</span>
Structural model of human TPI. (Upper panel) 
###end title 129
###begin p 130
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000030-Kinoshita1">[38]</xref>
###xml 126 131 <span type="species:ncbi:9606">human</span>
The pathogenic TPI variants Cys41Tyr, Glu104Asp, Gly122Arg, Ile170Val and Phe240Leu were assigned to the crystal structure of human TPI generated by Kinoshita et al [38]; NT: amino terminus. 
###end p 130
###begin p 131
###xml 0 13 0 13 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Lower panel)</bold>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
(Lower panel) Appearance of pathogenic TPI variants among TPI deficiency patients (c.h.: compound heterozygous; n.d.: not determined).
###end p 131
###begin title 132
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 63 68 <span type="species:ncbi:4932">yeast</span>
Human wild-type and pathogenic TPI variants can substitute for yeast TPI1.
###end title 132
###begin p 133
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A)</bold>
###xml 22 31 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 270 278 266 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-leu-ura</sup>
###xml 9 14 <span type="species:ncbi:4932">yeast</span>
###xml 120 125 <span type="species:ncbi:9606">human</span>
A) MR100 yeast cells (Deltatpi1) were transformed with the various p416GPD-based expression plasmids encoding wild-type human TPI as well as the pathogenic variants Met1_AAG, Cys41Tyr, Glu104Asp, Gly122Arg, Ile170Val or Phe240Leu, respectively, and plated on minimal SC -leu-ura medium supplemented with 3% ethanol/0.1% glucose.
###end p 133
###begin p 134
###xml 92 100 92 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-leu-ura</sup>
###xml 198 200 192 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B)</bold>
###xml 207 216 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
###xml 217 222 <span type="species:ncbi:4932">yeast</span>
Afterwards, single yeast clones were selected and grown as represented by the schemes on SC -leu-ura medium plates supplemented either with 2% glucose or with 3% ethanol/0.1% glucose at 30degreesC. B) MR100 Deltatpi1 yeast cells expressing wild-type TPI or the different pathogenic TPI variants were grown until logarithmic phase.
###end p 134
###begin p 135
Then, the same cell number of each culture was spotted as 5-fold serial dilutions onto glucose media or onto glucose media supplemented with different concentrations of lithium chloride. 
###end p 135
###begin p 136
###xml 75 80 <span type="species:ncbi:4932">yeast</span>
Plates were incubated for 3 days at 30degreesC and growth of the different yeast strains was analyzed.
###end p 136
###begin title 137
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Pathogenic TPI variants display catalytic activity in vivo.
###end title 137
###begin p 138
###xml 6 15 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 16 21 <span type="species:ncbi:4932">yeast</span>
MR100 Deltatpi1 yeast cells expressing wild-type as well as the pathogenic TPI variants Cys41Tyr, Glu104Asp, Gly122Arg, Ile170Val or Phe240Leu were grown until the logarithmic phase and equal cell numbers were collected.
###end p 138
###begin p 139
###xml 66 73 66 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
Afterwards, the enzymatic assay was performed as described in the Methods section.
###end p 139
###begin p 140
The catalytic activity of each pathogenic TPI variant was compared to the activity of the wild-type enzyme.
###end p 140
###begin p 141
###xml 78 83 <span type="species:ncbi:4932">yeast</span>
Each column represents the mean value of multiple measurements of 4 different yeast clones.
###end p 141
###begin p 142
Error bars indicate standard deviation.
###end p 142
###begin title 143
An alternative translation initiation start site within the TPI mRNA.
###end title 143
###begin p 144
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A)</bold>
###xml 30 35 <span type="species:ncbi:9606">human</span>
A) The first 17 codons of the human TPI sequence and the netstart scores are presented. The introduced mutations are indicated in bold letters.
###end p 144
###begin p 145
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B)</bold>
###xml 9 18 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 94 102 90 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Met1_AAG</sub>
###xml 107 115 103 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser3_TER</sub>
###xml 134 140 130 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
B) MR100 Deltatpi1 yeast cells were transformed with the respective plasmids encoding TPI, TPIMet1_AAG, TPISer3_TER or the variant TPI2ndATG.
###end p 145
###begin p 146
###xml 59 64 <span type="species:ncbi:4932">yeast</span>
Ethanol lysates were prepared from logarithmically growing yeast cultures and the expression level of the different TPI variants was analyzed by immunoblotting using polyclonal alpha-TPI serum.
###end p 146
###begin p 147
Please note that no sample was loaded in case of the lane marked with a dash.
###end p 147
###begin p 148
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
###xml 85 93 85 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Met1_AAG</sub>
###xml 109 117 109 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser3_TER</sub>
C) COS1 cells were transfected with the plasmids pEGFP-N1, pEGFP-N1-TPI, pEGFP-N1-TPIMet1_AAG or pEGFP-N1-TPISer3_TER.
###end p 148
###begin p 149
Cell lysates were prepared and the expression level of the different fusion proteins was analyzed by immunoblot using an alpha-GFP antibody.
###end p 149
###begin p 150
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D)</bold>
###xml 9 18 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 93 101 89 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Met1_AAG</sub>
###xml 108 114 104 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
D) MR100 Deltatpi1 yeast was transformed with expression plasmids encoding wild-type TPI, TPIMet1_AAG or TPI2ndATG.
###end p 150
###begin p 151
###xml 76 84 76 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-leu-ura</sup>
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
Afterwards, single yeast clones were selected and grown on the respective SC-leu-ura plates for 3 days at 30degreesC as indicated.
###end p 151
###begin title 152
Dimerization behavior of wild-type and pathogenic TPI variants.
###end title 152
###begin p 153
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A)</bold>
###xml 111 117 111 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
###xml 7 12 <span type="species:ncbi:4932">yeast</span>
A) The yeast two-hybrid strain L40ccua was co-transformed with plasmids encoding LexA-TPI, AD, AD-TPI or AD-TPI2ndATG as indicated.
###end p 153
###begin p 154
Afterwards, transformants were spotted on SC media lacking tryptophan and leucine, onto SC medium lacking tryptophan, leucine, histidine and uracil, or onto nylon membrane for analyzing the activity of the three reporter genes (left panel).
###end p 154
###begin p 155
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
For quantitative analysis of the lacZ reporter gene activity a liquid beta-galactosidase assay was performed (middle panel).
###end p 155
###begin p 156
Each column represents the mean value of four measurements.
###end p 156
###begin p 157
Error bars indicate the standard deviation.
###end p 157
###begin p 158
The expression level of the respective bait and prey proteins was analyzed by immunoblot analysis using antibodies against lexA or gal4AD (right panel).
###end p 158
###begin p 159
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B)</bold>
B) Strain L40ccua was transformed with plasmids encoding LexA-TPI and AD-TPI or LexA-TPI and the pathogenic variants AD-Cys41Tyr, AD-Glu104Asp, AD-Gly122Arg, AD-Ile170Val or AD-Phe240Leu, respectively.
###end p 159
###begin p 160
###xml 3 5 3 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
In C) plasmids encoding the LexA-Glu104Asp protein and AD-WT or LexA-Glu104Asp and the variants AD-Cys41Tyr, AD-Glu104Asp, AD-Gly122Arg, AD-Ile170Val or AD-Phe240Leu, respectively, were used.
###end p 160
###begin p 161
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 31 33 31 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B)</bold>
###xml 38 40 38 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
LacZ reporter gene activity in B) and C) was measured using a liquid beta-galactosidase assay.
###end p 161
###begin p 162
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D)</bold>
###xml 54 60 54 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2ndATG</sub>
D) Dimerization behavior between wild-type TPI and TPI2ndATG variants comprising the corresponding amino acid exchanges was analyzed as described before.
###end p 162
###begin p 163
###xml 42 47 <span type="species:ncbi:4932">yeast</span>
All experiments were repeated twice using yeast cells obtained from independent transformations.
###end p 163
###begin p 164
The intracellular level of the various bait or the prey proteins (in B-D) was monitored by immunoblot analysis using antibodies against lexA or gal4AD.
###end p 164
###begin title 165
Overexpression of the Glu104Asp TPI variant results in a reduced expression level of endogenous TPI.
###end title 165
###begin p 166
COS1 cells were transfected with pTL-Flag-TPI-WT or pTL-Flag-TPI-Glu104Asp as indicated.
###end p 166
###begin p 167
###xml 84 91 84 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
After 48h, lysates were prepared and analyzed by immunoblotting as described in the Methods section.
###end p 167
###begin p 168
Loading of equal protein concentrations was demonstrated by tubulin staining (lower panel).
###end p 168
###begin p 169
In addition, similar levels of FLAG-tagged wild-type TPI and FLAG-tagged Glu104Asp TPI was detected in the respective cell lysates (middle panel).
###end p 169
###begin title 170
###xml 11 15 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tpi1</italic>
###xml 16 21 <span type="species:ncbi:4932">yeast</span>
MR100 Deltatpi1 yeast cells expressing the Ile170Val TPI variant are hyperresistant to diamide.
###end title 170
###begin p 171
###xml 6 15 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;tpi1</italic>
###xml 197 200 193 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 16 21 <span type="species:ncbi:4932">yeast</span>
MR100 Deltatpi1 yeast cells expressing wild-type as well as the pathogenic TPI variants Cys41Tyr, Glu104Asp, Gly122Arg, Ile170Val or Phe240Leu were grown to stationary phase, serially diluted to OD600 values of 3.0, 1.0, 0.3, 0.1 and spotted onto SC medium plates containing different concentrations of diamide.
###end p 171
###begin p 172
###xml 84 89 <span type="species:ncbi:4932">yeast</span>
Sensitivity/resistance was determined by comparing the growth between the different yeast strains after incubating the plates for 3 days at 28degreesC.
###end p 172
###begin title 173
###xml 33 38 <span type="species:ncbi:9606">human</span>
Consequences of mutations within human TPI.
###end title 173
###begin p 174
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPI</italic>
Homozygous mutations within TPI affecting enzyme dimerization cause TPI deficiency, whereas homozygous mutations resulting in an inactive TPI allele are lethal.
###end p 174
###begin p 175
Compound heterozygous individuals having inherited one inactive and one allele defective in dimerization properties will develop TPI deficiency, whereas heterozygote individuals having inherited a heterozygote null allele have an evolutionary advantage. (+: wild-type TPI; -: TPI with aberrant dimerization property; 0: allele encoding no or a catalytically inactive TPI).
###end p 175
###begin p 176
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 176
###begin p 177
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: We are grateful to the FWF (Vienna, Austria; project S9302-B05 to M.B.), the European Community (for project MIMAGE, contr. no. 512020; to M.B.), and the Max Planck Society for providing financial support for this project.
###end p 177

